San Mateo, CA, United States of America

Kenneth E Schwartz


Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2003-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kenneth E Schwartz

Introduction

Kenneth E Schwartz is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bone mineral density and the formulation of dehydroepiandrosterone (DHEA). With a total of 5 patents to his name, Schwartz's work has the potential to impact many individuals suffering from related health issues.

Latest Patents

One of Schwartz's latest patents is focused on the treatment of subnormal bone mineral density. This method involves co-administering a calcitonin-like agent and a DHEA-like agent to increase an individual's bone mineral density (BMD). Additionally, he has disclosed methods for enhancing the effects of treatment with a calcitonin-like agent on BMD and for increasing BMD in individuals being treated with DHEA, particularly for conditions such as systemic lupus erythematosus (SLE). Another significant patent involves improved pharmaceutical formulations of DHEA, enriched in selected polymorphic forms for therapeutic applications. This formulation comprises DHEA in solid form, with at least 85% present as a single polymorph, along with at least one pharmaceutical excipient.

Career Highlights

Kenneth E Schwartz is associated with Genelabs Technologies, Inc., where he has been instrumental in advancing research and development in his field. His innovative approaches and dedication to improving health outcomes have established him as a respected figure in the pharmaceutical industry.

Collaborations

Throughout his career, Schwartz has collaborated with notable colleagues, including Marc J Gurwith and Jagdish Parasrampuria. These partnerships have contributed to the successful development of his patents and innovations.

Conclusion

Kenneth E Schwartz's contributions to the field of pharmaceuticals, particularly in the treatment of bone mineral density and DHEA formulations, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…